Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rebecca J Stack, Chris Bundy, Rachel A Elliott, John P New, J Martin Gibson & Peter R Noyce. (2011) Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 4, pages 127-135.
Read now
Read now
Articles from other publishers (11)
Manuel Urina-Jassir, Lina Johana Herrera-Parra, Juliana Alexandra Hernández Vargas, Ana María Valbuena-García, Lizbeth Acuña-Merchán & Miguel Urina-Triana. (2021) The effect of comorbidities on glycemic control among Colombian adults with diabetes mellitus: a longitudinal approach with real-world data. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Ghobad Moradi, Azad Shokri, Amjad Mohamadi-Bolbanabad, Bushra Zareie & Bakhtiar Piroozi. (2021) Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: A national survey in Iran. Heliyon 7:3, pages e06485.
Crossref
Crossref
Hadi Joud, Eslam Mohamed, Sabbir Mirza, Hozaifa Tabbaa, Mouaz Tabbaa, Firaas Khan, Noura Ayoubi, Madeline MacDonald, Laurie Woodard, Asa Oxner, Lucy Guerra, Chighaf Bakour & Abu-Sayeef Mirza. (2021) Prevalence and management of diabetes among the uninsured: A multicenter study in Tampa Bay, FL. Diabetes Research and Clinical Practice 171, pages 108560.
Crossref
Crossref
Lawrence Blonde, Stephen A. Brunton, Pavan Chava, Rong Zhou, Juliana Meyers, Keith L. Davis, Mehul R. Dalal & Andres DiGenio. (2019) Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice. Diabetes Spectrum 32:2, pages 93-103.
Crossref
Crossref
Jason I. Chiang, Bhautesh Dinesh Jani, Frances S. Mair, Barbara I. Nicholl, John Furler, David O’Neal, Alicia Jenkins, Patrick Condron & Jo-Anne Manski-Nankervis. (2018) Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review. PLOS ONE 13:12, pages e0209585.
Crossref
Crossref
A.I. Rakotoniaina, S.S. Rafaramalala, M.K. Ranaivosoa, A.M. Riel Mampionona & A. Rasamindrakotroka. (2018) Prévalence de l’hyperglycémie à jeun au sein du CHU Mitsinjo Betanimena, Tuléar, Madagascar. Médecine des Maladies Métaboliques 12:8, pages 702-704.
Crossref
Crossref
Irina A. Kurnikova, Aigerim U. Ualihanova, Tatiana A. Meleshkevich & Lyudmila V. Kiryanova. (2018) Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology. Diabetes mellitus 21:2, pages 118-127.
Crossref
Crossref
Roland E Schmieder, Anselm K Gitt, Cornelia Koch, Peter Bramlage, Taoufik Ouarrak & Diethelm Tschöpe. (2015) Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocrine Disorders 15:1.
Crossref
Crossref
Boon-How Chew, Ping-Yein Lee, Ai-Theng Cheong, Mastura Ismail, Mohamad-Adam Bujang, Jamaiyah Haniff, Sri-Wahyu Taher & Pik-Pin Goh. (2015) Complication profiles and their associated factors in Malaysian adult type 2 diabetes mellitus—an analysis of ADCM registry. International Journal of Diabetes in Developing Countries 35:3, pages 356-367.
Crossref
Crossref
Maryam Moghani Lankarani & Shervin Assari. (2015) Association between number of comorbid medical conditions and depression among individuals with diabetes; race and ethnic variations. Journal of Diabetes & Metabolic Disorders 14:1.
Crossref
Crossref
Welcome Mkululi Wami, Frank Buntinx, Stefaan Bartholomeeusen, Geert Goderis, Chantal Mathieu & Marc Aerts. (2013) Influence of chronic comorbidity and medication on the efficacy of treatment in patients with diabetes in general practice. British Journal of General Practice 63:609, pages e267-e273.
Crossref
Crossref